| Juan C Angelats, MD | |
|
6545 France Avenue South, Suite 540, Edina, MN 55435 | |
| (952) 927-4045 | |
| (952) 924-4133 |
| Full Name | Juan C Angelats |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 6545 France Avenue South, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598730756 | NPI | - | NPPES |
| 094M9AN | Other | BCBS OF MN | |
| HP35290 | Other | MN | HEALTH PARTNERS |
| 073826300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 42594 (Minnesota) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 42594 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infinite Health Collaborative Pa | 1052225042 | 772 |
| Allina Health System | 4587573613 | 3071 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Aitkin Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942277835 PECOS PAC ID: 4981514692 Enrollment ID: O20031107000093 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Infinite Health Collaborative Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164474250 PECOS PAC ID: 1052225042 Enrollment ID: O20040209000574 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Cuyuna Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861414518 PECOS PAC ID: 9537146550 Enrollment ID: O20040707000501 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Obstetrics And Gynecology Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871576116 PECOS PAC ID: 0749229748 Enrollment ID: O20050428001005 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan C Angelats, MD 6545 France Avenue South, Suite 540, Edina, MN 55435 Ph: (952) 927-4045 | Juan C Angelats, MD 6545 France Avenue South, Suite 540, Edina, MN 55435 Ph: (952) 927-4045 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Compartment Syndrome.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 1 days ago
Dr. April Batcheller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6565 France Ave S Ste 400, Edina, MN 55435 Phone: 952-225-1630 | |
Dr. Anne M Meschke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3625 W 65th St, Suite 100, Edina, MN 55435 Phone: 952-920-7001 Fax: 952-920-2245 | |
Rachel Amanda Harris, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3625 W 65th St Ste 100, Edina, MN 55435 Phone: 952-345-7070 Fax: 952-345-0472 | |
Mackenzie Thayer, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6405 France Ave S Ste W400, Edina, MN 55435 Phone: 952-920-2730 | |
Kimberly Anne Gerten, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6565 France Ave S Ste 200, Edina, MN 55435 Phone: 952-920-2200 Fax: 952-920-0866 | |
Suzin Cho, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6565 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-920-2200 Fax: 952-920-0866 | |
Annelise S Swigert, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3625 W 65th St, Suite 100, Edina, MN 55435 Phone: 952-920-7001 Fax: 952-920-2245 |